Trending Now
Business
Teva: Will The Dividend Survive?
Teva's (TEVA) $40 billion acquisition of Allergan's (AGN) generics business has left the company debt-laden, while its generics operations are experiencing pricing pressure. After...
Damian Lillard Researched Shock Exchange For NBA All Star Weekend Rap...
Damian Lillard, AKA Dame D.O.L.L.A. is considered one of the best rappers in the NBA, if not the very best. I first heard D.O.L.L.A. on...
Lifestyle today
Entertainment
Approval Of Epinephrine Nasal Spray Could Jump Start Insys
Insys is a specialty pharmaceutical company that manufactures and markets two main drugs - subsys and syndros. Subsys delivers fentanyl, an opioid analgesic offered...
Buffalo Players Clap Back At Obama After Upsetting Arizona
The NCAA tournament is full of surprises. The Arizona Wildcats were picked by many to win the National Championship. They had Deandre Ayton -...
Can Bausch Health Survive Another Competitive Threat?
Bausch Health (BHC) remains one of the most perplexing stocks on the market. I have been bearish on the name for a few years...
What Chistopher Rufo Gets Wrong About Claudine Gay Plagiarism Saga
As claims of antisemitism swirled around the presidents of the University of Pennsylvania, Harvard and MIT, Christopher Rufo and Chris Brunet presented...
Endo’s Effective Short Interest Reaches 200%
I am a major Endo (ENDP) bull. However, I would be remiss in not admitting that it has been one of the...
Cleveland Browns Mychal Kendricks, Goldman Analyst Charged In $1.2MM Insider Trading Scheme
Professional sports leagues, particularly the NFL, are sitting in the catbird seat. Through TV contracts, online streaming deals and now sports betting, the NFL...
Mychal Kendricks $1.2MM Insider Trading Scheme: Was Teyana Taylor Involved?
When it comes to money, stocks and insider trading people make strange bedfellows. Cleveland Browns Mychal Kendricks' $1.2 million insider trading scheme was noteworthy...
Allergan: Restasis Lawsuit From Kroger, Walgreen Could Cost Billions
Allergan (AGN) has gone to lengths to protect its patents. Drug makers have every right to protect their intellectual property. They practically have a...
























































































































